The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

被引:35
|
作者
Temian, Daiana Cosmina [1 ,2 ]
Pop, Laura Ancuta [1 ]
Irimie, Alexandra Iulia [3 ]
Berindan-Neagoe, Ioana [1 ,4 ,5 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Prosthet Dent & Dent Mat, Div Dent Propaedeut, Aesthet, 23 Marinescu St, Cluj Napoca 40015, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, MedFUTURE Res Ctr Adv Med, Cluj Napoca, Romania
[5] Oncol Inst Prof Dr I Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania
关键词
Breast neoplasms; DNA methylation; Histone code; Triple negative breast neoplasms; Untranslated RNA; LONG NONCODING RNAS; HISTONE DEACETYLASE INHIBITORS; PREDICTS SENSITIVITY; MOLECULAR PORTRAITS; DOWN-REGULATION; AXON GUIDANCE; MUTANT P53; EXPRESSION; IDENTIFICATION; BROMODOMAIN;
D O I
10.4048/jbc.2018.21.e41
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies-the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis-DNA methylation, histone modifications, and noncoding RNAs-advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.
引用
收藏
页码:233 / +
页数:16
相关论文
共 50 条
  • [1] Triple-negative/basal-like breast cancer: review
    Rakha, Emad A.
    Ellis, Ian O.
    PATHOLOGY, 2009, 41 (01) : 40 - 47
  • [2] Are triple-negative and basal-like breast cancer synonymous?
    Rakha, Emad
    Ellis, Ian
    Reis-Filho, Jorge
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 618 - 618
  • [3] The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma
    Naoto Kuroda
    Masahiko Ohara
    Kaori Inoue
    Keiko Mizuno
    Nokiaki Fujishima
    Nobumasa Hamaguchi
    Gang-Hong Lee
    Medical Molecular Morphology, 2009, 42 : 128 - 131
  • [4] The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma
    Kuroda, Naoto
    Ohara, Masahiko
    Inoue, Kaori
    Mizuno, Keiko
    Fujishima, Nokiaki
    Hamaguchi, Nobumasa
    Lee, Gang-Hong
    MEDICAL MOLECULAR MORPHOLOGY, 2009, 42 (02) : 128 - 131
  • [5] Triple-negative and basal-like breast cancer in Valdivia, Chile
    Poblete, M. T.
    Romero, C.
    Soto, P.
    Valencia, Y.
    Rios, M.
    Figueroa, C.
    Heise, K.
    VIRCHOWS ARCHIV, 2014, 465 : S120 - S120
  • [6] Are triple-negative tumours and basal-like breast cancer synonymous?
    Emad A Rakha
    David SP Tan
    William D Foulkes
    Ian O Ellis
    Andrew Tutt
    Torsten O Nielsen
    Jorge S Reis-Filho
    Breast Cancer Research, 9
  • [7] Triple-negative and basal-like breast cancer: implications for oncologists
    Lachapelle, J.
    Foulkes, W. D.
    CURRENT ONCOLOGY, 2011, 18 (04) : 161 - 164
  • [8] Triple-negative (basal-like) breast cancer: a new entity
    LA Carey
    Breast Cancer Research, 9
  • [9] Are triple-negative tumours and basal-like breast cancer synonymous?
    Rakha, Emad A.
    Tan, David S. P.
    Foulkes, William D.
    Ellis, Ian O.
    Tutt, Andrew
    Nielsen, Torsten O.
    Reis, Jorge S. -Filho
    BREAST CANCER RESEARCH, 2007, 9 (06):
  • [10] Triple-negative (basal-like) breast cancer: a new entity
    Carey, L. A.
    BREAST CANCER RESEARCH, 2007, 9 (01)